|
SocialPicks Sentiment:
N/A
** not enough data to be rated
|
This Quarter's Sentiment:
|
|
|
NBS Analysis & Videos »
NBS: Bull or Bear?
Bullish on NBS ...
NBS
|
|
|
+985.54%
in
13 days
AMEX:NBS) is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell collection process, in addition to fees charged to the centers for marketing and long-term storage. The Company was recently profiled at BusinessWeek online and will appear in the June 29 print magazine edition.
|
NeoStem (AMEX:NBS): BusinessWeek Mention
NBS
|
|
|
+1042.17%
in
17 days
<font> NeoStem, Inc. </font> (AMEX:NBS)is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell collection process, in addition to fees charged to the centers for marketing and long-term storage. <> The Company was recently <font> profiled at BusinessWeek online </font> and will appear in the June 29 pr...
|
NeoStem (AMEX:NBS): Pro-Active Research Initiates as Spec Buy
NBS
|
|
|
-11.54%
in
15 days
(closed on 06/19/09)
<> <font> NeoStem, Inc. </font> (AMEX:NBS)is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell collection process, in addition to fees charged to the centers for marketing and long-term storage. NeoStem targets its marketing efforts toward health conscious consumers to encourage them to donate and store their stem cell...
|
NeoStem Expands Beyond Stem Cell Banking
NBS
|
|
|
+38.30%
in
17 days
(closed on 06/04/09)
<> NeoStem (AMEX:NBS) is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell collection process, in addition to fees charged to the centers for marketing and long-term storage. NeoStem targets its marketing efforts toward health conscious consumers to encourage them to donate and store their stem cells as a form of bio-insuran...
|
Stem Cell Index Surges in Past Week
NBS
|
|
|
+7.43%
in
8 days
(closed on 05/18/09)
<> The stem cell trade was back in a big way over the past week, with several stocks in the <font> ETF Innovators Stem Cell Index </font> registering impressive gains, compared to market and biotech ETF benchmarks such as the S&P 500 SPDR (NYSE:SPY) +6%, iShares Nasdaq Biotech (NASDAQ:IBB) +2%, SPDR S&P Biotech (NYSE:XBI +4%). Hot stocks over the past week among the 40 component companies in the stem cell index include NeoStem (AMEX:NBS) +52.2%, Cytori Therapeutics (NASDAQ:CYTX) +37%, and Geron (NASDAQ:GERN) +22%. Two other widely followed stocks from the index registered smaller gains,...
|
Stem Cell Index: YTD Analysis, Banking on NeoStem
NBS
|
|
|
+45.83%
in
29 days
(closed on 05/10/09)
Related Tickers: NBS, IART, OSIR, STEM, GE, XLV, IBB, XBI, PBE, SPY Disclosure: No Positions The ETF Innovators Global Stem Cell and Regenerative Medicine Index tracks the performance of 40 stem cell and regenerative medicine companies on a global basis with market caps of less than $1 billion at the inception of the index. The total market value of the index will be tracked as a gauge of investor and trader sentiment toward stem cell companies from a starting value of 3,928 on 2/22/09. ...
|
People Bullish on NBS
People Bearish on NBS
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Be the first to start a discussion and earn 2 points.
More Resources
|
About Neostem Inc.
- Answers.com
